Measles Market Research Report By Vaccine Type (Live Attenuated Vaccine, Inactivated Vaccine, Combination Vaccine), By End User (Hospitals, Clinics, Research Institutions, Pharmacies), By Distribution Channel (Direct Procurement, Retail, Online Pharmacy), By Age Group (Children, Adults, Elderly) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. MEASLES MARKET, BY VACCINE TYPE (USD BILLION)
6.1. Live Attenuated Vaccine
6.2. Inactivated Vaccine
6.3. Combination Vaccine

7. MEASLES MARKET, BY END USER (USD BILLION)
7.1. Hospitals
7.2. Clinics
7.3. Research Institutions
7.4. Pharmacies

8. MEASLES MARKET, BY DISTRIBUTION CHANNEL (USD BILLION)
8.1. Direct Procurement
8.2. Retail
8.3. Online Pharmacy
9. MEASLES MARKET, BY AGE GROUP (USD BILLION)
9.1. Children
9.2. Adults
9.3. Elderly

10. MEASLES MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA

11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Measles Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Measles Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES
12.1. Merck and Co
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Pfizer
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Baxter International
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. AbbVie
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Roche
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Eli Lilly
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Johnson and Johnson
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Novartis
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Hikma Pharmaceuticals
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. CSL Limited
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Moderna
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. AstraZeneca
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. GlaxoSmithKline
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. BristolMyers Squibb
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Sanofi
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies

13. APPENDIX
13.1. References
13.2. Related Reports

LIST OF TABLES

TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 3. NORTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 4. NORTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 5. NORTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 6. NORTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 7. US MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 8. US MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 9. US MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 10. US MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 11. US MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 12. CANADA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 13. CANADA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 14. CANADA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 15. CANADA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 16. CANADA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 17. EUROPE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 18. EUROPE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 19. EUROPE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 20. EUROPE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 21. EUROPE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 22. GERMANY MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 23. GERMANY MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 24. GERMANY MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 25. GERMANY MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 26. GERMANY MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 27. UK MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 28. UK MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 29. UK MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 30. UK MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 31. UK MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 32. FRANCE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 33. FRANCE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 34. FRANCE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 35. FRANCE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 36. FRANCE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 37. RUSSIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 38. RUSSIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 39. RUSSIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 40. RUSSIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 41. RUSSIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 42. ITALY MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 43. ITALY MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 44. ITALY MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 45. ITALY MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 46. ITALY MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 47. SPAIN MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 48. SPAIN MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 49. SPAIN MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 50. SPAIN MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 51. SPAIN MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 52. REST OF EUROPE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 53. REST OF EUROPE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 54. REST OF EUROPE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 55. REST OF EUROPE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 56. REST OF EUROPE MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 57. APAC MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 58. APAC MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 59. APAC MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 60. APAC MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 61. APAC MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 62. CHINA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 63. CHINA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 64. CHINA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 65. CHINA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 66. CHINA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 67. INDIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 68. INDIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 69. INDIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 70. INDIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 71. INDIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 72. JAPAN MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 73. JAPAN MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 74. JAPAN MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 75. JAPAN MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 76. JAPAN MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 77. SOUTH KOREA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 78. SOUTH KOREA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 79. SOUTH KOREA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 80. SOUTH KOREA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 81. SOUTH KOREA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 82. MALAYSIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 83. MALAYSIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 84. MALAYSIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 85. MALAYSIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 86. MALAYSIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 87. THAILAND MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 88. THAILAND MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 89. THAILAND MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 90. THAILAND MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 91. THAILAND MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 92. INDONESIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 93. INDONESIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 94. INDONESIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 95. INDONESIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 96. INDONESIA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 97. REST OF APAC MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 98. REST OF APAC MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 99. REST OF APAC MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 100. REST OF APAC MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 101. REST OF APAC MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 102. SOUTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 103. SOUTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 104. SOUTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 105. SOUTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 106. SOUTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 107. BRAZIL MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 108. BRAZIL MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 109. BRAZIL MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 110. BRAZIL MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 111. BRAZIL MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 112. MEXICO MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 113. MEXICO MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 114. MEXICO MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 115. MEXICO MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 116. MEXICO MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 117. ARGENTINA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 118. ARGENTINA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 119. ARGENTINA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 120. ARGENTINA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 121. ARGENTINA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 127. MEA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 128. MEA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 129. MEA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 130. MEA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 131. MEA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 132. GCC COUNTRIES MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 133. GCC COUNTRIES MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 134. GCC COUNTRIES MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 135. GCC COUNTRIES MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 136. GCC COUNTRIES MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 137. SOUTH AFRICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 138. SOUTH AFRICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 139. SOUTH AFRICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 140. SOUTH AFRICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 141. SOUTH AFRICA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 142. REST OF MEA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY VACCINE TYPE, 2019-2035 (USD BILLIONS)
TABLE 143. REST OF MEA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
TABLE 144. REST OF MEA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 145. REST OF MEA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY AGE GROUP, 2019-2035 (USD BILLIONS)
TABLE 146. REST OF MEA MEASLES MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP

LIST OF FIGURES

FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA MEASLES MARKET ANALYSIS
FIGURE 3. US MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 4. US MEASLES MARKET ANALYSIS BY END USER
FIGURE 5. US MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 6. US MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 7. US MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 9. CANADA MEASLES MARKET ANALYSIS BY END USER
FIGURE 10. CANADA MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 11. CANADA MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 12. CANADA MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE MEASLES MARKET ANALYSIS
FIGURE 14. GERMANY MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 15. GERMANY MEASLES MARKET ANALYSIS BY END USER
FIGURE 16. GERMANY MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 17. GERMANY MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 18. GERMANY MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 20. UK MEASLES MARKET ANALYSIS BY END USER
FIGURE 21. UK MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 22. UK MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 23. UK MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 25. FRANCE MEASLES MARKET ANALYSIS BY END USER
FIGURE 26. FRANCE MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 27. FRANCE MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 28. FRANCE MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 30. RUSSIA MEASLES MARKET ANALYSIS BY END USER
FIGURE 31. RUSSIA MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 32. RUSSIA MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 33. RUSSIA MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 35. ITALY MEASLES MARKET ANALYSIS BY END USER
FIGURE 36. ITALY MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 37. ITALY MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 38. ITALY MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 40. SPAIN MEASLES MARKET ANALYSIS BY END USER
FIGURE 41. SPAIN MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 42. SPAIN MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 43. SPAIN MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 45. REST OF EUROPE MEASLES MARKET ANALYSIS BY END USER
FIGURE 46. REST OF EUROPE MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 47. REST OF EUROPE MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 48. REST OF EUROPE MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC MEASLES MARKET ANALYSIS
FIGURE 50. CHINA MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 51. CHINA MEASLES MARKET ANALYSIS BY END USER
FIGURE 52. CHINA MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 53. CHINA MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 54. CHINA MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 56. INDIA MEASLES MARKET ANALYSIS BY END USER
FIGURE 57. INDIA MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 58. INDIA MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 59. INDIA MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 61. JAPAN MEASLES MARKET ANALYSIS BY END USER
FIGURE 62. JAPAN MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 63. JAPAN MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 64. JAPAN MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 66. SOUTH KOREA MEASLES MARKET ANALYSIS BY END USER
FIGURE 67. SOUTH KOREA MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 68. SOUTH KOREA MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 69. SOUTH KOREA MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 71. MALAYSIA MEASLES MARKET ANALYSIS BY END USER
FIGURE 72. MALAYSIA MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 73. MALAYSIA MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 74. MALAYSIA MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 76. THAILAND MEASLES MARKET ANALYSIS BY END USER
FIGURE 77. THAILAND MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 78. THAILAND MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 79. THAILAND MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 81. INDONESIA MEASLES MARKET ANALYSIS BY END USER
FIGURE 82. INDONESIA MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 83. INDONESIA MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 84. INDONESIA MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 86. REST OF APAC MEASLES MARKET ANALYSIS BY END USER
FIGURE 87. REST OF APAC MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 88. REST OF APAC MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 89. REST OF APAC MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA MEASLES MARKET ANALYSIS
FIGURE 91. BRAZIL MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 92. BRAZIL MEASLES MARKET ANALYSIS BY END USER
FIGURE 93. BRAZIL MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 94. BRAZIL MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 95. BRAZIL MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 97. MEXICO MEASLES MARKET ANALYSIS BY END USER
FIGURE 98. MEXICO MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 99. MEXICO MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 100. MEXICO MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 102. ARGENTINA MEASLES MARKET ANALYSIS BY END USER
FIGURE 103. ARGENTINA MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 104. ARGENTINA MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 105. ARGENTINA MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 107. REST OF SOUTH AMERICA MEASLES MARKET ANALYSIS BY END USER
FIGURE 108. REST OF SOUTH AMERICA MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 109. REST OF SOUTH AMERICA MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 110. REST OF SOUTH AMERICA MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA MEASLES MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 113. GCC COUNTRIES MEASLES MARKET ANALYSIS BY END USER
FIGURE 114. GCC COUNTRIES MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 115. GCC COUNTRIES MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 116. GCC COUNTRIES MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 118. SOUTH AFRICA MEASLES MARKET ANALYSIS BY END USER
FIGURE 119. SOUTH AFRICA MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 120. SOUTH AFRICA MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 121. SOUTH AFRICA MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA MEASLES MARKET ANALYSIS BY VACCINE TYPE
FIGURE 123. REST OF MEA MEASLES MARKET ANALYSIS BY END USER
FIGURE 124. REST OF MEA MEASLES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 125. REST OF MEA MEASLES MARKET ANALYSIS BY AGE GROUP
FIGURE 126. REST OF MEA MEASLES MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF MEASLES MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF MEASLES MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: MEASLES MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: MEASLES MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: MEASLES MARKET
FIGURE 133. MEASLES MARKET, BY VACCINE TYPE, 2025 (% SHARE)
FIGURE 134. MEASLES MARKET, BY VACCINE TYPE, 2019 TO 2035 (USD Billions)
FIGURE 135. MEASLES MARKET, BY END USER, 2025 (% SHARE)
FIGURE 136. MEASLES MARKET, BY END USER, 2019 TO 2035 (USD Billions)
FIGURE 137. MEASLES MARKET, BY DISTRIBUTION CHANNEL, 2025 (% SHARE)
FIGURE 138. MEASLES MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2035 (USD Billions)
FIGURE 139. MEASLES MARKET, BY AGE GROUP, 2025 (% SHARE)
FIGURE 140. MEASLES MARKET, BY AGE GROUP, 2019 TO 2035 (USD Billions)
FIGURE 141. MEASLES MARKET, BY REGIONAL, 2025 (% SHARE)
FIGURE 142. MEASLES MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS